|Molecular response to cetuximab and efficacy of preoperative cetuximab-based chemoradiation in rectal cancer|
A Debucquoy, K Haustermans, A Daemen, S Aydin, L Libbrecht, ...
Journal of Clinical Oncology 27 (17), 2751-2757, 2009
|T-cell responses to survivin in cancer patients undergoing radiation therapy|
D Schaue, B Comin-Anduix, A Ribas, L Zhang, L Goodglick, JW Sayre, ...
Clinical Cancer Research 14 (15), 4883-4890, 2008
|The link between the multiverse of immune microenvironments in metastases and the survival of colorectal cancer patients|
M Van den Eynde, B Mlecnik, G Bindea, T Fredriksen, SE Church, ...
Cancer Cell 34 (6), 1012-1026. e3, 2018
|A kernel-based integration of genome-wide data for clinical decision support|
A Daemen, O Gevaert, F Ojeda, A Debucquoy, JAK Suykens, C Sempoux, ...
Genome medicine 1 (4), 1-17, 2009
|Hypoxia in human colorectal adenocarcinoma: comparison between extrinsic and potential intrinsic hypoxia markers|
L Goethals, A Debucquoy, C Perneel, K Geboes, N Ectors, H De Schutter, ...
International Journal of Radiation Oncology* Biology* Physics 65 (1), 246-254, 2006
|A new approach to the validation of tissue microarrays|
L Goethals, C Perneel, A Debucquoy, H De Schutter, D Borghys, N Ectors, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2006
|Radiotherapy-activated cancer-associated fibroblasts promote tumor progression through paracrine IGF1R activation|
J Tommelein, E De Vlieghere, L Verset, E Melsens, J Leenders, ...
Cancer research 78 (3), 659-670, 2018
|Biomarkers for cetuximab-based neoadjuvant radiochemotherapy in locally advanced rectal cancer|
PP Grimminger, P Danenberg, K Dellas, D Arnold, C Rödel, JP Machiels, ...
Clinical Cancer Research 17 (10), 3469-3477, 2011
|Double blind randomized phase II study with radiation+ 5-fluorouracil±celecoxib for resectable rectal cancer|
A Debucquoy, S Roels, L Goethals, L Libbrecht, E Van Cutsem, K Geboes, ...
Radiotherapy and Oncology 93 (2), 273-278, 2009
|Integrating microarray and proteomics data to predict the response on cetuximab in patients with rectal cancer|
A Daemen, O Gevaert, T De Bie, A Debucquoy, JP Machiels, B De Moor, ...
Biocomputing 2008, 166-177, 2008
|EGF61 polymorphism predicts complete pathologic response to cetuximab-based chemoradiation independent of KRAS status in locally advanced rectal cancer patients|
S Hu-Lieskovan, D Vallbohmer, W Zhang, D Yang, A Pohl, MJ Labonte, ...
Clinical Cancer Research 17 (15), 5161-5169, 2011
|Molecular responses of rectal cancer to preoperative chemoradiation|
A Debucquoy, L Goethals, K Geboes, S Roels, WH Mc Bride, ...
Radiotherapy and oncology 80 (2), 172-177, 2006
|Molecular and clinico-pathological markers in rectal cancer: a tissue micro-array study|
A Debucquoy, L Goethals, L Libbrecht, C Perneel, K Geboes, N Ectors, ...
International journal of colorectal disease 24 (2), 129-138, 2009
|Integration of epidermal growth factor receptor inhibitors with preoperative chemoradiation|
A Debucquoy, JP Machiels, WH McBride, K Haustermans
Clinical Cancer Research 16 (10), 2709-2714, 2010
|Morphological features and molecular markers in rectal cancer from 95 patients included in the European Organisation for Research and Treatment of Cancer 22921 trial …|
A Debucquoy, L Libbrecht, V Roobrouck, L Goethals, W McBride, ...
European journal of cancer 44 (6), 791-797, 2008
|Quantitative imaging outperforms molecular markers when predicting response to chemoradiotherapy for rectal cancer|
I Joye, A Debucquoy, CM Deroose, V Vandecaveye, E Van Cutsem, ...
Radiotherapy and Oncology 124 (1), 104-109, 2017
|Combining bevacizumab and chemoradiation in rectal cancer. Translational results of the AXEBeam trial|
M Verstraete, A Debucquoy, J Dekervel, J van Pelt, C Verslype, E Devos, ...
British journal of cancer 112 (8), 1314-1325, 2015
|The ESTRO Breur Lecture 2010: toward a tailored patient approach in rectal cancer|
K Haustermans, A Debucquoy, M Lambrecht
Radiotherapy and Oncology 100 (1), 15-21, 2011
|Predicting the tumor response to chemoradiotherapy for rectal cancer: model development and external validation using MRI radiomics|
P Bulens, A Couwenberg, M Intven, A Debucquoy, V Vandecaveye, ...
Radiotherapy and Oncology 142, 246-252, 2020
|Development and validation of an MRI-based model to predict response to chemoradiotherapy for rectal cancer|
P Bulens, A Couwenberg, K Haustermans, A Debucquoy, V Vandecaveye, ...
Radiotherapy and Oncology 126 (3), 437-442, 2018